Cytokinetics Inc - Company Profile
Powered by
All the data and insights you need on Cytokinetics Inc in one report.
- Save hours of research time and resources with
our up-to-date Cytokinetics Inc Strategy Report
- Understand Cytokinetics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Cytokinetics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Cytokinetics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
John T. Henderson, M.D.
Chairman Executive BoardMr. John T. Henderson, M.D. has been Chairman of the company since April 2022. Prior to this, he served as Director of the company from 2009. He also served as a Consultant to the pharmaceutical industry from 2000. Dr. Henderson was served as a Vice President in the Pfizer Pharmaceuticals Group Pfizer Inc. He previously served as Vice President, Research & Development in Europe, and later Japan, as well as Vice President, Medical for Pfizer’s Europe, U.S., and International Pharmaceuticals groups.
Robert I. Blum
President; Director; Chief Executive Officer Executive BoardMr. Robert I. Blum has been the President, Chief Executive Officer and Director of the company since January 2007. Prior to this role, he served as the company’s President and and held other senior-level positions at the company in research and development, finance, business development, corporate development, legal and commercial operations.
Ching W. Jaw
Senior Vice President; Chief Financial Officer Senior ManagementMr. Ching W. Jaw has been the Chief Financial Officer and Senior Vice President of the company since June 2017. Prior to this, he served as the Chief Financial Officer of North America Pharmaceuticals at Sanofi from 2015 to 2017. Mr. Ching worked as the Chairman of North America Regional Finance Council and as the Chief Financial Officer for Ventana Medical Systems, a member of the Roche Group from 2012 to 2015.
Robert C. Wong
Vice President; Chief Accounting Officer Senior ManagementMr. Robert C Wong has been the Vice President and Chief Accounting Officer of the company since May 2019. Prior to this, he served in various roles of responsibility which includes reporting, accounting, internal controls and most recently as Chief Accounting Officer and Interim Controller at Genentech for over 23 years. Previously, Mr. Robert served as Audit Manager at Ernst & Young LLP.
Kari K. Loeser
Chief Compliance Officer; Vice President Senior ManagementMs. Kari K. Loeser has been the Vice President and Chief Compliance Officer of the company since November 2021. Prior to this, she served as the US Healthcare Compliance and Privacy Officer and Senior Corporate Counsel at Vifor Pharma Inc. Previously, Ms. Loeser served as Senior Director and Senior Compliance Counsel at Jazz Pharmaceuticals.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward